FDA Delaying Decision on Its Shot for Adolescents – NBC 5 Dallas-Fort Worth
U.S. regulators are delaying their decision on Moderna's COVID-19 vaccine for 12- to 17-year-olds while investigating the rare risk of heart infection, the company said on Sunday.
The U.S. Food and Drug Administration told…